XML 30 R19.htm IDEA: XBRL DOCUMENT v3.25.1
Joint Ventures, VIEs and Other Investments
 6 Months Ended
Mar. 28, 2025
Equity Method Investments and Joint Ventures [Abstract]  
Joint Ventures, VIEs and Other Investments Joint Ventures, VIEs and Other Investments
For the Company's consolidated variable interest entities ("VIE") joint ventures, the carrying value of assets and liabilities was $157.3 million and $134.2 million, respectively, as of March 28, 2025 and $161.9 million and $122.7 million, respectively, as of September 27, 2024. There are no consolidated VIEs that have debt or credit facilities.
For the Company's proportionate consolidated VIEs, the carrying value of assets and liabilities was $126.6 million and $117.7 million, respectively, as of March 28, 2025, and $138.8 million and $138.0 million, respectively, as of September 27, 2024.
The carrying values of our investments in equity method joint ventures in the Consolidated Balance Sheets (reported in Other Noncurrent Assets: Miscellaneous) as of March 28, 2025 and September 27, 2024 were $35.6 million and $36.6 million, respectively. Additionally, net (loss) income from equity method joint ventures (reported in Revenues in the Consolidated Statements of Earnings) was $(0.2) million and $3.8 million, respectively, during the three months ended March 28, 2025 and March 29, 2024, with $3.5 million and $6.5 million respectively, for the corresponding six month periods. As of March 28, 2025, the Company's equity method investment carrying values do not include material amounts exceeding their share of the respective joint ventures' reported net assets.
Accounts receivable from unconsolidated joint ventures accounted for under the equity method was $20.7 million and $12.3 million as of March 28, 2025 and September 27, 2024, respectively.